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WHAT THIS PAPER ADDS
 The article reports the ﬁrst tensiomyographic study on biomechanical properties of the gastrocnemius medialis muscle in patients
with intermittent claudication. Compared to healthy individuals, the contraction properties of the gastrocnemius medialis muscle
of claudicants have been found to be different regarding the time and velocity of electrically elicted contractions. The increased
fatigability of the studied muscle found in claudicants could represent a novel target to study the effectiveness of different
treatment modalities for patients with symptomatic peripheral arterial disease (PAD).a r t i c l e i n f o
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Background: We attempted to identify possible differences in the contractility of the gastrocnemius
medialis (GM) muscle between healthy controls and individuals with peripheral arterial disease (PAD)
and intermittent lower-limb claudication.
Methods: The GM muscles of 17 PAD patients and 17 healthy controls were examined with tensio-
myography. Single or multiple electrical impulses were used to trigger muscle contractions, and the time
and amplitude of contractions were measured.
Results: After single-impulse stimulation, the GM muscles of PAD patients showed signiﬁcantly shorter
contraction times (P < 0.001) than the GM muscles of controls. During 1 min of repetitive electrical
stimulation, the contraction velocity of the controls’ GM muscles typically showed a sustained increase
throughout the stimulation period, whereas in PAD patients, a signiﬁcant decrease in contraction velocity
was observed after 30 s. The onset of muscle fatigue was unrelated to the ankle brachial index (ABI) of
the examined leg. When the legs of PAD patients with higher and lower ABIs were compared to each
other, no signiﬁcant differences were found regarding the time and amplitude of contraction after single-
impulse stimulation.
Conclusions: The GM muscles of individuals with intermittent claudication contract more quickly and
fatigue earlier than the GM muscles of healthy controls. Because the contraction time, measured with
tensiomyography, reﬂects the individual’s muscle ﬁbre composition, our ﬁndings may reﬂect a shift from
type I ﬁbres to type II ﬁbres in the GM muscles of PAD patients. Our data support the idea that calf
myopathy is present in claudication-prone patients and, in part, determines the clinical manifestations of
PAD.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.a 1c, 6000 Koper, Slovenia.
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ciety for Vascular Surgery. PublishPeripheral arterial disease (PAD) is a common disorder, affecting
a ﬁfth of the population older than 55 years.1 The most common
symptom of PAD is intermittent claudication, characterised by
a cramp-like pain in the calves that occurs during walking and is
relieved by rest.2 Claudication symptoms are thought to be theed by Elsevier Ltd. All rights reserved.
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substrate delivery to the working leg muscles.
Although lowered leg arterial pressure is emblematic of PAD,
several studies have found little or no correlation between
decreased leg perfusion and exercise performance in patients with
PAD.3e5 Improvements in claudication symptoms after exercise
training also appear to be unrelated to changes in lower-limb
arterial blood ﬂow.6,7 The current perspective on the pathogen-
esis of PAD, therefore, also includes abnormalities in the muscle’s
structure and metabolic function that may contribute to muscle
weakness and walking limitations.8 In fact, a new clinical entity
called the ‘myopathy of peripheral arterial disease’ was recently
introduced9 to deﬁne this set of abnormalities. Understanding the
speciﬁc role of the calf muscle in the pathophysiology of PAD could
help to set new end points for evaluating the effectiveness of
current therapies (e.g., exercise, percutaneous interventions,
surgery and angiogenic gene therapy).
To elucidate the contraction characteristics of the gastrocnemius
medialis (GM) muscle in patients with claudication, we compared
the contractility and fatigability of the GMmuscle between a group
of PAD patients and a group of healthy individuals. To do this, we
used a novel, non-invasive method called ‘tensiomyography (TMG)’
to measure the mechanical response of the GM muscle to single or
multiple electrical stimuli. We hypothesised that the fatigability of
the GM muscle is signiﬁcantly more pronounced in PAD patients
than in healthy individuals, and that the onset of muscle fatigue
depends on the individual’s ankle-brachial index (ABI). To our
knowledge, this is the ﬁrst TMG study of the biomechanical char-
acteristics of calf muscles in symptomatic PAD patients.
Material and Methods
Participants
With approval from the National Medical Ethics Committee, 17
individuals with PAD and 17 healthy individuals (Table 1) were
enrolled in the study over a period of 6 months. Patients with PAD
were identiﬁed consecutively from a list of candidates waiting for
a percutaneous intervention on the lower-limb arteries at the
Clinical Department for Vascular Diseases at the University Clinical
Center of Ljubljana, Slovenia. Controls were volunteers from the
hospital staff. All participants were informed about the nature of
the procedure, and written consent was obtained from each
participant.
Inclusion and exclusion criteria
Patients with PAD were included in the study if they had
persistent claudication for 3 months or longer, had an ABI of lessTable 1
Clinical Patient Characteristics.
Patient Characteristics PAD Patients Controls
No. patients 17 17
Male/Female 14/3 12/5
Age, yr 62.7  10.3 58.3  8.2
Height, cm 172.0  9.9 172.2  5.3
Weight, kg 76.2  13.6 80.5  16.4
BMI, kg/m2 25.6  3.1 27.2  4.0
Hypertension,N (%) 14 (82) 0
Diabetes, N (%) 5 (29) 0
Hyperlipidaemia, N (%) 12 (71) 0
Smokers, N (%) 12 (71) 0
Lower ABI leg 0.50  0.16 /
Higher ABI leg 0.81  0.16 1.07  0.10
PAD ¼ peripheral arterial disease; BMI ¼ body mass index; ABI ¼ ankle brachial
index; Data are presented as number, as mean  SD, or as percentage.than 0.8 and were able to walk between 50 and 350 m. Exclusion
criteria were serious co-morbidities that interfered with walking,
insulin-dependent diabetes mellitus, advanced neuromuscular
disease, signiﬁcant leg oedema, critical limb ischaemia and prior
lower-limb surgical revascularisation. Healthy individuals
(controls) were included if their resting ABI was normal and if they
had no history of diabetes, leg swelling or cardiovascular or
neuromuscular disease.
ABI measurement
Before starting the ABI measurement, participants rested supine
for 5 min. By an established method,10 a hand-held Doppler probe
(Super-Dopplex II, Huntleigh Healthcare, Cardiff, UK) was used to
obtain systolic pressure values on the dorsalis pedis and tibialis
posterior arteries of both legs and on both brachial arteries.
Appropriately sized cuffs were applied and deﬂated at a rate of
3 mmHg s1. The ABI was calculated for each leg by dividing the
average pressure in each leg by the average brachial pressure. If the
two average brachial pressures differed by 10 mmHg or more, the
higher value was used.11 In PAD patients, the leg with the lower ABI
was labelled the lower-ABI leg and the other the higher-ABI leg.
Tensiomyography
TMG is a non-invasive method for investigating the contraction
properties of skeletal muscles.12 It measures changes in the diam-
eter of the muscle belly during an electrically evoked isometric
contraction. The thickening of the muscle belly is recorded with
a mechanical displacement sensor (Fig. 1) connected to a computer
(Fig. 2).13 Every contraction is displayed as a displacement-over-
time curve, which is then used to calculate different parameters
(Fig. 3). In previous studies,14e16 2 parameters were found to be
particularly useful: the time of contraction (Tc) and the maximal
radial displacement (Dm) of the muscle belly. The Tc has a strong
correlation (r ¼ 0.93) with the percentage of type I (fatigue-resis-
tant) ﬁbres in the muscles studied.17 This relationship allows
indirect estimation of the ﬁbre-type composition of the studied
muscles. The clinical signiﬁcance of the Dm of the muscle belly is
less clear, but it has been correlated with the muscle’s architec-
ture15 and longitudinal twitch torque.12 We calculated the velocity
of contraction (Vc) from the Dm and Tc parameters (Vc ¼ Dm/Tc).
A decrease of more than 20% of maximum Vc during repetitiveFigure 1. Electrodes and displacement sensor positioned for TMG measurements on
the gastrocnemius medialis muscle.
Figure 2. Equipment used for TMG measurements e a. computer for data analysis, b.
generator of electrical impulses, c. muscle belly displacement sensor, d. stimulating
electrodes.
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muscle fatigue.18
After a 5-min rest, the participant was turned face down on
a standard examination table with his or her ankles supported by
a 10-cm-high pad. A digital displacement sensor (G40, RLS Inc.,
Ljubljana, Slovenia) was applied perpendicular to the outermost
part of the GMmuscle. The tip of the sensor was pressed against the
skin with an initial contact pressure of 77 N mm2, as was done in
a previous study.13 From this measuring point, two rounded, 5-cm,
self-adhesive electrodes (PALS Axelgaard Manufacturing Co. Ltd.,
Fallbrook, California, USA) were placed 5 cm distally (anode) and
5 cm proximally (cathode) over the muscle.
Single-impulse stimulation
A single contraction of the passive GM muscle was elicited with
a square-wave electric pulse of 1 ms duration, delivered trans-
cutaneously by a direct current stimulator (TMGZD1, EMF-Furlan &
Co., Ljubljana, Slovenia) controlled by a computer. Stepwise incre-
ments in current were delivered, separated by rest periods of 30 s,
until no further increase in twitch amplitude was seen. This
method was previously described by Russ et al.18 Three maximal
twitches were then averaged and used for further analysis.
Multiple-impulse stimulation
After a 5-min rest, we continued with a multiple electrical
stimulations protocol, which consisted of 1 min of intermittentFigure 3. Typical curve obtained with tensiomyography after single-twitch stimula-
tion of a normal skeletal muscle. Dm ¼Maximal radial displacement; Tc ¼ Contraction
time between the 10% and 90% Dm.(1-Hz) electrical stimulation of the GM muscle. The intensity used
was the same as described for single-impulse stimulations. For each
single muscle twitch, the Tc and the Dm were measured. The
computer calculated the Vc for each muscle twitch, and the data
were plotted on a velocity/time graph (Figs. 5 and 6). Fatigue time
(FT) was deﬁned as the time elapsed from the start of tetanic
stimulation until Vc had decreased to more than 20% of its
maximum value.
Statistics
All data were tested for homogeneity by using the
KolmogoroveSmirnov test before further statistical analysis was
conducted. Means and standard deviations were used to describe
patient characteristics and control parameters, whereas means and
standard error were used to describe variables. One-way analysis of
variance was used to compare Tc and Dm means after single-
impulse stimulation. Group membership (PAD patient or control)
was set as an independent factor. A Tukey post hoc analysis was
performed to test for additional differences between the groups,
and R2 values were computed to estimate effect size. To compare
the Vc of the GMmuscle of PAD patients and controls after multiple
impulse stimulation, we performed a two-way analysis of variance.
We divided the stimulation period into 10-s intervals and deﬁned
the presence or absence of claudication as two independent factors.
A Tukey post hoc analysis was performed to further analyse
possible differences in TMG parameters. The correlation between
FT and ABI was tested with the Pearson correlation coefﬁcient. All
statistical analysis was performed with Statistical Package for the
Social Sciences (SPSS) software (SPSS Inc, Chicago, IL, USA). Statis-
tical signiﬁcance was deﬁned at the P < 0.05 level unless otherwise
noted.
Results
ABI measurements
The mean ABI values in PAD patients were 0.50 0.16 for lower-
ABI legs and 0.81  0.16 for higher-ABI legs (P < 0.001). In controls,
the mean ABI was 1.07  0.10.
Single-impulse stimulation
The Dm of the GMmuscle was not signiﬁcantly different among
the PAD patients’ legs with lower ABI, the legs with higher ABI, and
the legs of controls (P ¼ 0.361), whereas the mean Tc wasFigure 4. Graph shows the contraction time of gastrocnemius medialis muscles after
single-impulse stimulation of the legs with lower and higher ABI in PAD patients and
the legs of healthy controls. Tc ¼ contraction time; ABI ¼ ankle brachial index
*P ¼ 0.005 between the legs of controls and the legs with lower ABI in PAD patients
**P ¼ 0.044 between the legs of controls and the legs with higher ABI in PAD patients.
Figure 5. Typical result obtained with tensiomyography in a healthy individual by stimulating the gastrocnemius medialis muscle for 60 s with 1 Hz and supramaximal electrical
impulses. a.) Maximal radial displacement b.) Contraction time and c.) Velocity of contraction (radial displacement).
M. Gasparini et al. / European Journal of Vascular and Endovascular Surgery 44 (2012) 170e176 173(F ¼ 5.952; P ¼ 0.005) (Fig. 4). Tukey post hoc analysis revealed
signiﬁcant differences between the GM muscle Tc of PAD patients’
legs with lower ABI and controls (P¼ 0.005), as well as between the
PAD patients’ legs with higher ABI and controls (P ¼ 0.044). There
were no signiﬁcant differences between the higher-ABI and lower-
ABI legs in PAD patients (P ¼ 0.674).Figure 6. Typical result obtained with tensiomyography in a PAD patient by stimulating
impulses. a.) Maximal radial displacement b.) Contraction time and c.) Velocity of contractMultiple-impulse stimulation
When the GM muscles of controls were stimulated with low-
frequency (1-Hz) electrical impulses of supramaximal amplitude,
an increase in Vc was typically observed throughout the stimula-
tion period (Fig. 5c). A similar, near-sigmoid, curve was noticed forthe gastrocnemius medialis muscle for 60 s with 1 Hz and supramaximal electrical
ion (radial displacement).
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throughout the stimulation period (Fig. 5b).
When the same stimulation protocol was applied to the GM
muscles of PAD patients, a different velocity/time curve pattern
emerged (Fig. 6). The radial displacement peaked earlier (after
approximately 30 s) and was followed by a slow decrease towards
its initial level (Fig. 6a). Inversely, the Tc shortened during the ﬁrst
30 s and then slowly rose towards its initial level (Fig. 6b). As
a result, the Vc rose during the ﬁrst half of the stimulation period
and then gradually diminished to its baseline value at the end of the
stimulation period (Fig. 6c).
Because of substantial differences in peak Vc among the studied
subjects, we normalised the subjects’ Vcs to values between 0 and
1. Analysis of these normalised values revealed differences in mean
Vc between the PAD patients and the controls (Fig. 7).
To test for changes in response over the stimulation period, we
divided the stimulation period into the following intervals: 0e10 s,
11e20 s, 21e30 s, 31e40 s, 41e50 s and 51e60 s. Time interval was
set as the ﬁrst independent factor and the presence or absence of
claudication as the second independent factor. The presence of
claudicationwas associated with a signiﬁcant time interval effect at
P< 0.001 and an interaction effect at P< 0.001. In post hoc analysis,
we found signiﬁcant differences between Vc values at the ﬁrst time
interval and at all intervals after the 31st second (Fig. 7).
The average GM muscle FT was signiﬁcantly lower in PAD
patients (31.7  11.7 s) than in controls (58.2  0.7 s; P < 0.001).
However, there was no signiﬁcant correlation between the FTof the
GM muscle and the PAD patients’ baseline ABI value (R ¼ 0.21;
P ¼ 0.24). The size of the illness effect on the GM muscle’s time to
fatigue was 37.85.
Discussion
This study demonstrates that the GM muscles of PAD patients
possess different contraction characteristics compared to the GM
muscles of healthy individuals. The Tc of the GMmuscle was found
to be signiﬁcantly shorter in PAD patients, suggesting a predomi-
nance of type II ﬁbres in this particular calf muscle. In PAD patients,
no differences between lower-ABI legs and higher-ABI legs were
observed in terms of Tc or Dm. Repetitive electrical stimulation of
the GMmuscles of healthy individuals resulted in a steady increase
in Vc, whereas in PAD patients, Vc rose only in the ﬁrst 30 s of
stimulation before decreasing towards starting levels because of
muscle fatigue. The time of onset of muscle fatiguewas unrelated to
the individual’s ABI.
Decreased lower-limb arterial blood ﬂow is the main clinical
ﬁnding in patients with PAD. However, patients with similar lower-
limb haemodynamic conditions show very different exercise0.6
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Figure 7. Graph shows changes in the velocity of contraction (normalized to maximal
velocity and averaged across 10-s intervals) of the gastrocnemius medialis muscle in
PAD patients and controls. The muscles were stimulated for 60 s with 1 Hz and
supramaximal electrical impulses. *P < 0.001 for PAD patients versus controls.tolerances.3e5 Increased fatigability of the PAD patients’ GM
medialis muscles, found both in our study and in others,19,20
supports the idea that besides a clear arterial insufﬁciency,
patients with PAD have a speciﬁc PAD-related ‘muscle insufﬁ-
ciency’, which contributes to their lower-than-expected muscle
performance and premature fatigue. Our data also suggest that calf
muscle phenotype is altered in PAD patients so that the proportion
of fatigue-prone type II ﬁbres is increased.
To quantify muscle fatigue, volitional and non-volitional (elec-
trically elicited) fatigue tests are used.21 TMG, which was used in
our study, is based on a transcutaneous electric stimulation and
a synchronous measurement of speciﬁc contraction properties of
the studied muscle Because supramaximal tetanic stimulation is
not tolerated by some patients,22 we used low-frequency electrical
stimulation to trigger muscle fatigue. Stimulation of the GMmuscle
of healthy individuals for 1 min at the 1-Hz frequency used in our
protocol resulted in an enhanced muscle output, which was prob-
ably due to the post-activation potentiation phenomenon.23 This
phenomenon is attributed to phosphorylation of myosin regulatory
light chains, which makes actin and myosin more sensitive to
myoplasmic Ca2þ. No such effect is seen at high stimulation
frequencies, because the concentration of Ca2þ has already reached
its ‘saturation’ level.24 We observed this potentiation pattern also
during the ﬁrst half of the stimulation period in the GM muscle of
PAD patients; afterwards, however, the amplitude and velocity of
contraction started to decrease, marking the onset of muscle
fatigue. We did not test different stimulation frequencies for trig-
gering muscle fatigue; this should be done in the future to better
deﬁne the ideal stimulation protocol.
Very few studies have explored the effect of low-frequency
electrical stimulation on the fatigability of calf muscles in PAD
patients. Cole et al.25 measured the plantar ﬂexion torque in six
healthy young adults during 5 min of transcutaneous electrical
stimulation of the triceps surae under different thigh cuff occlusion
pressures. They found that with undisturbed lower-leg circulation,
the generated force steadily rose over the stimulating period, while
complete ischaemia of the leg caused a 47% drop in the generated
force. The authors, therefore, concluded that low-force twitch
contractions of calf muscles are extremely sensitive to impaired
blood perfusion.
Anderson and colleagues26 studied changes in plantar ﬂexion
torque in 30 patients during 5 min of electrically evoked twitch
contractions of calf muscles A ﬁfth of the patients could not
complete the procedure because of unbearable discomfort. In
patients who ﬁnished the test, twitch torque had declined to
73%  30% of the initial value after 5 min. The stimulation protocol
used in our study was better tolerated by patients (we had no
dropouts among the 34 participants) and was seemingly more
sensitive, because muscle fatigue was observed after only 30 s of
stimulation. However, different types of subjects and different end
points were measured in the two studies, so no ﬁrm conclusions
can be drawn.
Muscle fatigue is the most common clinical symptom of PAD,
but it is also the leading symptom in a variety of other chronic
diseases. In similar studies that used electrically induced contrac-
tions, premature muscle fatigue was found in the calf muscles of
patients with chronic heart failure27 and in the thigh muscles of
patients with chronic obstructive pulmonary disease.28 Multiple
mechanisms for this increased fatigability were suggested,
including peripheral neuropathy, disuse atrophy, ﬁbre type shift,
skeletal muscle myopathy, changes related to hypoxia and systemic
inﬂammation.29 These alterations could have affected also the
studied muscles in our PAD patients and this could explain why we
did not ﬁnd any differences in Tc and Dm between the lower-ABI
and higher-ABI legs in PAD patients. Hiatt et al.30 and Jansson
Figure 8. Proposed biomechanical changes in the gastrocnemius muscles of claudicants.
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ﬁbre types, ﬁbre dimension, capillary density or myoglobin content
in biopsy samples from the GMmuscles of PAD patients whose legs
had signiﬁcantly different ABI values. However, the lack of differ-
ences between individuals’ left and right legs in the parameters
measured in our study could be also the result of the inability of
single-impulse stimulation to detect discrete biomechanical
differences between the legs. Future studies of PAD patients should
include repetitive impulse stimulation protocols for both legs.
It was shown in previous studies13,32 that the time of contrac-
tion measured with TMG correlates well (r ¼ 0.88e0.93) with the
proportion of type I ﬁbres in biopsy samples. Therefore, the shorter
Tcs and increased fatigability found in our PAD patients during
repetitive GM muscle stimulation indicate a predominance of type
II (anaerobic and fatigue-prone) ﬁbres in those patients’ GM
muscles. These results agree with those of McGuigan et al.33 and
Ambrosio et al.,34 who found that the GM muscles of PAD patients
have decreased expression of MHC1 isoforms (characteristic for
type I, fatigue-resistant ﬁbres) and increased expression of MHC 2b
and MHC 2x isoforms (characteristic for type IIb and IIx ﬁbres,
respectively). They concluded that repeated episodes of ischaemia
trigger a shift from type I to type II ﬁbres, the last being subject to
earlier energy depletion and muscle fatigue (Fig. 8). The impact of
PAD on muscle phenotype is clearly an important area of research,
and there is a need to establish what effect these pathophysiologic
alterations might have on exercise performance.
This study has some limitations: the number of patients studied
is relatively low, and the patients were heterogeneous in terms of
sex, age, ABI and the level of the diseased arterial segment. In
addition, conditions other than PAD could have inﬂuenced leg
performance.35Conclusions
In this study, the GM muscles of PAD patients were shown to
contract faster and fatigue earlier than those of healthy controls.
This increased fatigability was independent of severity of patients’
PAD (as indicated by the patients’ ABI), which conﬁrmed the lack
of relationship between leg arterial blood ﬂow and muscle
performance.
A shift in the ﬁbre-type composition of the GM muscle from
fatigue-resistant (type I) to fatigue-prone (type II) ﬁbres could
explain greater fatigability in PAD patients. But it is probable that
a complex interaction between a variety of systemic (e.g., neurop-
athy, myopathy, disuse and smoking) and local factors (e.g., reduced
blood ﬂow, hypoxia, reperfusion injury, oxidative stress, muscle
atrophy, metabolic and histomorphologic changes) determines the
level of muscle insufﬁciency. Calf muscle biomechanical function
could be a novel parameter to consider when therapies to improve
walking distance are tested.Funding
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